Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Polycystic Ovary Syndrome 18Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 11Lung Neoplasms 9Recurrence 7Neoplasm Metastasis 5Colonic Neoplasms 5Breast Neoplasms 5Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, T-Cell, Peripheral 4Infertility 4Neoplasms 3Lymphoma, T-Cell 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sezary Syndrome 2Papillomavirus Infections 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Insulin Resistance 2Infertility, Female 2Hyperandrogenism 2Head and Neck Neoplasms 2Diabetes, Gestational 2Carcinoma, Transitional Cell 2Atypical Squamous Cells of the Cervix 2

Interventions

pembrolizumab 91Gemcitabine 55Nivolumab 49Cisplatin 38atezolizumab 31Carboplatin 30avelumab 25enfortumab vedotin 23Docetaxel 23Magnetic Resonance Spectroscopy 18Ipilimumab 17Paclitaxel 16Mitomycin 15Specimen Handling 14durvalumab 11toripalimab 10sacituzumab govitecan 10Pemetrexed 10cabozantinib 9Taxes 8vinflunine 7Cyclophosphamide 7tislelizumab 6Injections 6Bevacizumab 6pemigatinib 5fludarabine 5disitamab vedotin 5Standard of Care 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Transitional Cell × Folic Acid × Clear all
NCT00722553 2019-12-17

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Acrotech Biopharma Inc.

Phase 2 Completed
30 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Recurrence

NCT03193788 2017-06-21

PREMIER

Asan Medical Center

Phase 3 Unknown
74 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡